Google backs a biotech start-up
A little-known biotech startup has ginned some substantial investment backing through the help of Google co-founder Sergey Brin. Brin originally loaned seed funds to 23andMe, which was co-founded by his new wife Anne Wojcicki. Now Google has come in to back the company along with Genentech CEO Arthur Levinson, a Google director, New Enterprise Associates and Mohr Davidow Ventures. The fledgling company is focused on DNA analysis technology that will shed light on the genetic information encoded in individual's 23 chromosomes. The $2.6 million Brin originally advanced to the company is lunch money to the Google founder, who's worth billions.
- here's the report on 23andMe from AHN
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
